US Patent Issued to Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH), Technische Universitat Dresden on May 5 for "Method for determining the risk to develop type 1 diabetes" (German Inventors)

ALEXANDRIA, Va., May 5 -- United States Patent no. 12,620,489, issued on May 5, was assigned to Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH) (Neuherberg, Germany) and Technische Universitat Dresden (Dresden, Germany).

"Method for determining the risk to develop type 1 diabetes" was invented by Anette-G. Ziegler (Munich), Ezio Bonifacio (Munich), Christiane Winkler (Munich), Jan Krumsiek (Munich), Fabian Theis (Garching, Germany) and Peter Achenbach (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of determining whether a subject is at risk of developing type 1 diabetes by determining the genetic risk score (GRS) of a su...